Combined CBT and DBT Skills Group for High-Risk Psychosis
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment Combined CBT and DBT Skills Group for High-Risk Psychosis?
Research shows that Dialectical Behavior Therapy (DBT) skills training can improve mental health in patients with various mental disorders, and combining Cognitive Behavioral Therapy (CBT) with social skills training has shown benefits for patients with schizophrenia. These findings suggest that integrating CBT and DBT skills could be effective for high-risk psychosis.12345
Is the combined CBT and DBT Skills Group generally safe for humans?
Research on Dialectical Behavior Therapy (DBT) programs, which include skills training similar to those in the combined CBT and DBT Skills Group, shows that patients, including those with psychosis, experienced improvements without hospitalizations or suicide attempts during treatment, suggesting it is generally safe.46789
How is the CBT-DBT Skills Group treatment for high-risk psychosis different from other treatments?
The CBT-DBT Skills Group treatment is unique because it combines elements of Cognitive Behavioral Therapy (CBT) and Dialectical Behavioral Therapy (DBT) to specifically target emotion regulation difficulties in individuals with psychosis, which are often a priority for these patients. This integrated approach is novel as it adapts DBT skills, originally developed for other conditions, to address the specific needs of those with psychosis.16101112
What is the purpose of this trial?
This trial tests a new group therapy combining CBT and DBT for teens at high risk of psychosis. The therapy includes regular sessions to help manage stress, think more flexibly, and improve social skills. The goal is to see if this approach can improve mental health and functioning in these young people.
Research Team
Leslie Horton, PhD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for adolescents and young adults aged 13-18 who are at clinical high-risk (CHR) for psychosis. Participants must be receiving services from the HOPE team at the University of Pittsburgh and meet specific criteria indicating a risk for developing a psychotic disorder, such as having certain symptoms or family history.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a weekly skills group integrating CBT and DBT for 15 weeks, focusing on stress management, self-disturbance improvement, and social skills enhancement.
Midpoint Assessment
Feasibility and outcome measures are collected to assess progress and group satisfaction.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of symptoms and functioning.
Treatment Details
Interventions
- Skills Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
Substance Abuse and Mental Health Services Administration (SAMHSA)
Collaborator